Deal or no deal: a health perspective

  • Ricky Brathwaite, PhD, is the chief executive of the Bermuda Health Council

    Ricky Brathwaite, PhD, is the chief executive of the Bermuda Health Council


For the Bermuda Health Council, the news last week of Argus buying Island Health Services and the Family Practice Group was akin to an insurance company in the United States purchasing medical practices that accounted for 100 million Americans — and the entity charged with overseeing the country’s health system being none the wiser.

This lack of being informed is even more concerning when the health council is legislatively responsible for the licensure of said health insurers. Yes, we had heard some very recent rumblings around the potential ownership of a laboratory a few days before, but the larger scope of medical practices was not transmitted.

The act of adding complex structures within an already complicated health system without regard to adequate accountability and consideration of system ramifications is irresponsible. As we continue to review the deal, we will also study the regulatory processes at various levels that allowed this to occur without logical signoffs.

So what could this mean?

This type of deal is not new to the landscape of global healthcare, but to Bermuda, and within a small community, such a move is unprecedented and potentially destabilising.

The Bermuda Health Council Act 2004 has provisions to more strongly regulate health-system events, such as in the regulation of health businesses. Still some of these regulations have been never formally enacted. Therefore, the robust legislative enforcement needed to minimise system risk is deficient at present.

This insurer-practice move has the potential to further segment the population into good and bad risks, and further create disparities in the resources that are available to those who have and those who do not.

Right now, a big part of the instability of our system is that the Government carries a lot of the adverse health risk without the funding to counteract it properly. At the same time, the private sector can have more flexibility with lower levels of risk. These types of potential social imbalance of resources and inequitable availability of treatment options are at the core of the frustrations seen globally in social protests and movements.

A “dismiss unintended consequences” approach to creating a pie with two distinct halves never works out well for a country as a whole — although it does typically greatly benefit a few.

That is true, but could it actually work for their clients? Of course, it can. You would hope that such large investments into these types of deals would create benefits for the patients involved. It may also be the spark that the system needed to show urgency in the changes that are required to be made.

More specific to the deal, we believe there are talented and experienced individuals in each of the respective organisations who can improve healthcare if given the resources and environment to do so, and we trust their ability and propensity to provide significant returns on their investments.

As with any other health-related organisation, we will strive to support the achievement of better health outcomes by the relevant entities, which will also require us to do more monitoring and evaluation of this partnership. While some may be angered, this deal should not create a retort of castigating the new product into its own isolated space, but it rather necessitate the BHeC to hold them even closer within our reach to create best pathways for its success. At the end of the day, patient lives are involved.

Some of the pros of such a partnership in other places have included:

• The insurer having more of a relationship with the patient — for the purpose of reducing their costs and unnecessary utilisation

• Establishment of standards in health information technology systems and population health programmes

• Better management of patient care, and improved quality and outcomes. (For example, having a “closed” system makes it easier to implement best practices in primary care and ensure that patients have access to high-quality care.)

• Insurers exercising more case management over how physicians practise medicine, where they refer patients — what overseas care facility they are sent to, what local care provider — and what medications they prescribe. (This may not seem like a benefit, but if, for example, an insurer can require that more generic drugs are prescribed, then we can close the gap between where we should be in prescribing generic drugs, about 90 per cent; and where we are, about 55 per cent.)

Why now? That’s an interesting question. A few months ago, this type of dramatic change and consolidation within the system was being shouted down in town halls and on podiums as being monopolistic and limiting patient choice. This type of change, although similarly proposed to be done through a larger-scale, non-profit government initiative, was being touted as being out of line with putting patients first.

The feedback was that the existing health system should be left alone and more focused on creating a more robust public health system for the uninsured and underinsured. However, an interesting thing was brewing as those concepts and arguments were being presented. Apparently, while passionate pleas were made for non-interference of external forces into revenue streams and care decisions, paradoxical conversations were taking place behind the closed doors.

Typically, in the face of system reforms and change, there is a reaction to protect one’s interests — so maybe this should have been expected. For example, once the hospital funding became fixed, we observed stakeholders quickly beginning to think in terms of controlling their own spending, protecting revenue from potential future reforms, and expanding healthcare access for their cohorts to maintain a competitive advantage. Maybe these types of deals would have come even quicker, if not for this pandemic.

What can we realistically expect? That is such a hard question to answer because Bermuda does not work in the same way that some of these other countries operate. However, we should be mindful that not everything in such a healthcare structure should be assumed to work well.

In the United States, similarly structured health maintenance organisations — commonly referred to as HMOs — fell out of favour because they limited patient choice and forced some physicians to deny some care, especially for patients with illnesses where costs outpaced insurance premiums.

As people demanded more choice, the part about controlling costs became lost and the systems that were created to produce a little more control failed. However, if done right, and if quality is a core component of a deal — and measured accordingly — health spending has been seen to be 6 per cent lower than that of providers in traditional fee-for-service contracts. We hope that these partners have learnt from the experiences of those overseas.

What’s next? Health reform associated with the Bermuda Health Plan will progress, along with a broader Bermuda Health Strategy. Not because of a stubborn approach to making changes, but because large-system reform is critically needed. It is not yet clear how such larger-system reforms will or will not work well with the Argus deal.

A concern, however, is that as reforms are being finalised and the funding models are being established, there will be an insurance and provider arms race for who can create the largest partnerships. While this marginally helps in defragmenting a very disparate system with lots of incongruent parts, it actually creates a new problem where you have strong silos with inconsistent strategies on how to meet countrywide health goals. We as a system have to be more strategic and a lot more collaborative in terms of what happens next.

In conclusion, some credit must go to Argus and the medical practices of Island Health Services and the Family Practice Group for their progressive thinking for our local market. This being despite the deal’s stealth, and still under review, clear lack of non-prohibition.

This move does reinforce and revalidate the challenges that are faced within a health system, and the shocks that often occur within it. Covid-19 has taught us that the status quo of our health system is not sufficient, and that change must occur so that we can be in best positions to face whatever shocks may come next.

As change comes, we must also adjust just as rapidly to new norms and make sure that we are always focused on the end goal — that being a more comprehensive and integrated health system that seeks to put people first and elevates the health of not some, but every one of our communities.

Ricky Brathwaite, PhD, is the chief executive of the Bermuda Health Council, a quasi-autonomous, non-governmental organisation tasked with regulating, co-ordinating and enhancing the delivery of health services in Bermuda

You must be registered or signed-in to post comment or to vote.

Published Jul 6, 2020 at 8:00 am (Updated Jul 6, 2020 at 8:37 am)

Deal or no deal: a health perspective

What you
Need to
Know
1. For a smooth experience with our commenting system we recommend that you use Internet Explorer 10 or higher, Firefox or Chrome Browsers. Additionally please clear both your browser's cache and cookies - How do I clear my cache and cookies?
2. Please respect the use of this community forum and its users.
3. Any poster that insults, threatens or verbally abuses another member, uses defamatory language, or deliberately disrupts discussions will be banned.
4. Users who violate the Terms of Service or any commenting rules will be banned.
5. Please stay on topic. "Trolling" to incite emotional responses and disrupt conversations will be deleted.
6. To understand further what is and isn't allowed and the actions we may take, please read our Terms of Service
7. To report breaches of the Terms of Service use the flag icon

  • Take Our Poll

    Today's Obituaries

    eMoo Posts